TGFBR2 and squamous cell carcinoma: We then exploited a previously published ribosome profiling and short-read RNA-seq data set carried out in the identical wild-type keratinocyte and HrasG12V; Tgfbr2 null squamous cell carcinoma lines to compute differential translational efficiencies as a measure of protein synthesis rates per mRNA molecule [19].